Flash glucose monitoring significantly reduces time in hyperglycemia or hypoglycemia in people with diabetes at high risk for either outcome, with the benefit sustained for at least 6 months, real-world study data show.
Researchers show that closed-loop insulin delivery achieves markedly better glucose control than standard insulin management in hospitalized patients with hyperglycemia receiving enteral or parenteral nutrition.
Patients with type 2 diabetes who experience a large reduction in glycated hemoglobin levels within 6 months of starting metformin therapy have a lower risk for adverse outcomes than those who do not achieve early glycemic control, study results suggest.
Research shows that switching to an insulin pump does not improve glycemic control in patients referred to an educational program after struggling to control their type 1 diabetes with multiple daily injections.
Results of a randomized trial suggest that continuous glucose monitoring can be used without regular confirmatory blood glucose monitoring among adult insulin pump users with well-controlled type 1 diabetes.
Having a physician who speaks their native language is associated with improved glycemic control among diabetes patients with limited English proficiency, but may be less important for medication adherence, research suggests.
Results of a preclinical study confirm that microvascular destabilization caused by diabetes exacerbates cardiac ischemic damage, but this damage may be partially combated with treatment to induce neovascularization.